S286: LONG-TERM EFFICACY AND SAFETY RESULTS FROM AN ONGOING OPEN-LABEL PHASE 2 STUDY OF PARSACLISIB FOR THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

Geahča maid

• S286: LONG-TERM EFFICACY AND SAFETY RESULTS FROM AN ONGOING OPEN-LABEL PHASE 2 STUDY OF PARSACLISIB FOR THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
  Dahkki: W. Barcellini, et al.
  Almmustuhtton: (2022-06-01)
• Treatment of autoimmune hemolytic anemias
  Dahkki: Alberto Zanella, et al.
  Almmustuhtton: (2014-10-01)
• Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
  Dahkki: Bainan Liu, et al.
  Almmustuhtton: (2013-01-01)
• Educational Case: Warm Autoimmune Hemolytic Anemia
  Dahkki: Ruta Arays MD, et al.
  Almmustuhtton: (2020-11-01)
• PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT
  Dahkki: Wilma Barcellini, et al.
  Almmustuhtton: (2023-08-01)